Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling

  • Jing Zhong
  • , Xiaofang He
  • , Xinxin Gao
  • , Qiaohong Liu
  • , Yu Zhao
  • , Ying Hong
  • , Weize Zhu
  • , Juan Yan
  • , Yifan Li
  • , Yan Li
  • , Ningning Zheng
  • , Yiyang Bao
  • , Hao Wang
  • , Junli Ma
  • , Wenjin Huang
  • , Zekun Liu
  • , Yuanzhi Lyu
  • , Xisong Ke
  • , Wei Jia
  • , Cen Xie*
    • Yiyang Hu*, Lili Sheng*, Houkai Li*
*Corresponding author for this work

Research output: Contribution to journal › Journal article › peer-review

91 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology